Lotus Eye Hospital and Institute Limited (LOTUSEYE.NS)
INR 70.01
(-1.3%)
INR 70.01
(-1.3%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 72.17 Million INR | 28.69% |
| 2022 | 56.08 Million INR | -19.74% |
| 2021 | 69.88 Million INR | 6.98% |
| 2020 | 65.32 Million INR | -9.11% |
| 2019 | 71.87 Million INR | 10.03% |
| 2018 | 65.31 Million INR | -13.77% |
| 2017 | 75.75 Million INR | 55.13% |
| 2016 | 48.83 Million INR | -8.62% |
| 2015 | 53.44 Million INR | -23.99% |
| 2014 | 70.31 Million INR | -2.2% |
| 2013 | 71.89 Million INR | 29.08% |
| 2012 | 55.69 Million INR | 10.14% |
| 2011 | 50.57 Million INR | -46.49% |
| 2010 | 94.5 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -594.09 Million INR | -923.13% |
| 2023 FY | 72.17 Million INR | 28.69% |
| 2023 Q2 | 80.7 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 72.17 Million INR | 0.0% |
| 2022 FY | 56.08 Million INR | -19.74% |
| 2022 Q2 | 80.85 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 56.08 Million INR | 0.0% |
| 2021 Q4 | 69.88 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 69.88 Million INR | 6.98% |
| 2021 Q2 | 88.82 Million INR | 0.0% |
| 2020 Q2 | 67.39 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 65.32 Million INR | 0.0% |
| 2020 FY | 65.32 Million INR | -9.11% |
| 2019 FY | 71.87 Million INR | 10.03% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 70.43 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 71.87 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 65.31 Million INR | 0.0% |
| 2018 Q2 | 71.94 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 65.31 Million INR | -13.77% |
| 2017 Q4 | 75.75 Million INR | 6.88% |
| 2017 Q1 | - INR | -100.0% |
| 2017 FY | 75.75 Million INR | 55.13% |
| 2017 Q2 | 79.32 Million INR | 0.0% |
| 2017 Q3 | 70.87 Million INR | -10.65% |
| 2016 Q4 | 48.83 Million INR | 0.0% |
| 2016 Q2 | 59.87 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 FY | 48.83 Million INR | -8.62% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 53.44 Million INR | -23.99% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q4 | 53.44 Million INR | 0.0% |
| 2015 Q2 | 60.77 Million INR | 0.0% |
| 2014 Q4 | 70.31 Million INR | 0.0% |
| 2014 FY | 70.31 Million INR | -2.2% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 85.11 Million INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q2 | 56.3 Million INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 FY | 71.89 Million INR | 29.08% |
| 2013 Q4 | 71.89 Million INR | 0.0% |
| 2012 FY | 55.69 Million INR | 10.14% |
| 2012 Q3 | - INR | -100.0% |
| 2012 Q2 | 57.94 Million INR | 0.0% |
| 2012 Q4 | 55.69 Million INR | 0.0% |
| 2011 Q4 | 50.57 Million INR | 0.0% |
| 2011 FY | 50.57 Million INR | -46.49% |
| 2010 Q4 | 94.5 Million INR | 0.0% |
| 2010 FY | 94.5 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Apollo Hospitals Enterprise Limited | 94.32 Billion INR | 99.923% |
| Artemis Medicare Services Limited | 5.16 Billion INR | 98.604% |
| Aster DM Healthcare Limited | 129.61 Billion INR | 99.944% |
| Fortis Healthcare Limited | 47.32 Billion INR | 99.847% |
| HealthCare Global Enterprises Limited | 18.42 Billion INR | 99.608% |
| Indraprastha Medical Corporation Limited | 2.45 Billion INR | 97.06% |
| Krishna Institute of Medical Sciences Limited | 17.58 Billion INR | 99.59% |
| Max Healthcare Institute Limited | 35.91 Billion INR | 99.799% |
| Max India Limited | 1.92 Billion INR | 96.241% |
| Global Health Limited | 13.98 Billion INR | 99.484% |
| Narayana Hrudayalaya Limited | 27.39 Billion INR | 99.737% |
| Rainbow Children's Medicare Limited | 9.05 Billion INR | 99.203% |
| Shalby Limited | 5.99 Billion INR | 98.797% |